Dr. Mann Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-11-2024
- Paid Up Capital ₹ 0.10 M
as on 07-11-2024
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.41 M
as on 07-11-2024
- Revenue -71.76%
(FY 2023)
- Profit -76.13%
(FY 2023)
- Ebitda -69.75%
(FY 2023)
- Net Worth 15.34%
(FY 2023)
- Total Assets 5.39%
(FY 2023)
About Dr. Mann Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.41 M.
Nehul Gullaiya, Hanuv Mann, and Inderjit Mann serve as directors at the Company.
- CIN/LLPIN
U33125DL2020PTC360998
- Company No.
360998
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jan 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Dr. Mann Lifesciences Private Limited offer?
Dr. Mann Lifesciences Private Limited offers a wide range of products and services, including Oxygen & Nitrogen Gas Plants, Oxygen & Nitrogen Gas Plant.
Who are the key members and board of directors at Dr. Mann Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Inderjit Mann  | Managing Director | 29-Jan-2020 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nehul Gullaiya | Director | 29-Jan-2020 | Current |
| Hanuv Mann | Director | 23-Aug-2023 | Current |
Financial Performance of Dr. Mann Lifesciences.
Dr. Mann Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 71.76% decrease. The company also saw a substantial fall in profitability, with a 76.13% decrease in profit. The company's net worth Soared by an impressive increase of 15.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Mann Lifesciences?
Unlock access to Dr. Mann Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Yastra Tech Private LimitedActive 4 years 10 months
Nehul Gullaiya, Hanuv Mann and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 16 Jul 2021 | ₹0.41 M | Open |
Canara Bank Creation Date: 21 May 2021 | ₹4.00 M | Open |
How Many Employees Work at Dr. Mann Lifesciences?
Unlock and access historical data on people associated with Dr. Mann Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Mann Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Mann Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
